Effectiveness of the MindBridge Mobile Health Module for Young Adults at Risk of Suicide

Sponsor
Jiangsu Medical College
Study ID
NCT07767604
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Suicidal Ideation

Eligibility Criteria

Sex
ALL
Age
18 Years - 24 Years
Healthy Volunteers
Not accepted

Interventions

  • MindBridge Mobile Health Intervention — BEHAVIORAL
    MindBridge is an 8-week mobile health intervention delivered through a WeChat mini-program. The intervention is informed by dialectical behavior therapy (DBT) and is designed to reduce suicide-related thoughts and behaviors among young adults at mild-to-moderate suicide risk. Participants assigned to the intervention arm will receive MindBridge in addition to treatment as usual (TAU).
  • Attention-Matched General Well-Being Program — BEHAVIORAL
    Participants assigned to the control arm will receive an attention-matched general well-being program for 8 weeks in addition to treatment as usual (TAU). The program is designed to provide a comparable level of participant attention without delivering the specific therapeutic components of the MindBridge intervention.

Study Details

This study will evaluate the effectiveness of MindBridge, a dialectical behavior therapy (DBT)-informed mobile health module delivered through a WeChat mini-program, among Chinese young adults aged 18 to 24 years with mild-to-moderate suicide risk. In the randomized controlled trial, 84 participants will be randomized 1:1 to receive MindBridge plus treatment as usual or an attention-matched general well-being program plus treatment as usual for 8 weeks. Assessments will be conducted at baseline, week 4, week 8, and 1-month follow-up. The primary outcome is suicide-related thoughts and behaviors. Secondary outcomes include depression, anxiety, emotion regulation, sleep quality, perceived social support, academic self-efficacy, and problematic internet use. This randomized controlled trial is the effectiveness-evaluation component of a broader sequential mixed methods study involving the development and evaluation of MindBridge.

Key Dates

First listed
Aug 17, 2026
Start date
Mar 31, 2027
Status verified
Aug 2026
Primary completion
Oct 31, 2027
Completion
Nov 30, 2027

Study Design

Enrollment
84 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: MindBridge + Treatment as Usual
    Participants assigned to this arm will receive the MindBridge mobile health intervention in addition to treatment as usual (TAU) for 8 weeks.
  • Active Comparator: Attention-Matched Control + Treatment as Usual
    Participants assigned to this arm will receive an attention-matched general well-being program in addition to treatment as usual (TAU) for 8 weeks.

Primary Outcome Measure

Change in Suicide-Related Thoughts and Behaviors Measured by the SSBI [ Time Frame: Baseline to 8 weeks ]

Central Contacts

Related Studies